Roth Capital Starts Prosensa (RNA) at Neutral
Tweet
Share
E-mailGet Alerts RNA Hot Sheet
Price: $13.19 +3.21%
Rating Summary:
11 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
11 Buy, 12 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Roth Capital initiated coverage on Prosensa (NASDAQ: RNA) with a Neutral rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Prosensa click here. For more ratings news on Prosensa click here.
Shares of Prosensa closed at $10.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Nomura/Instinet Starts PB Fintech Limited (POLICYBZ:IN) at Neutral
- B.Riley Starts Nutex Health (NUTX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
